Nestle introduces nutritional solutions for cellular aging

Image credit: Nestle Health Science

Celltrient provides targeted nutrition that helps revitalize natural cellular processes related to age-associated cellular decline

Switzerland based Nestlé Health Science has announced the launch of Celltrient Cellular Nutrition, a breakthrough and comprehensive range of nutritional solutions that work cell by cell. The specialized Celltrient range is formulated with cellular nutrients that help address three of the main drivers of Age-Associated Cellular Decline (AACD). AACD can lead to reductions in daily energy, muscle function, immune support, and overall health.  

The Celltrient product range features cellular nutrients studied in more than 20 clinical trials in humans.  The cellular nutrients in the Celltrient range help to replenish NAD+, which is important for natural energy production, renew the power plants in muscle cells, and replenish essential building blocks for the protective antioxidant Glutathione. 

Celltrient is available in beverage and supplement form, and the product range provides three core benefits depending on individual needs, including:  

  • Celltrient Cellular Protect provides a patented blend of amino acids – glycine and NAC (GlyNAC) – that helps replenish amino acids important for making Glutathione. Glutathione is a powerful antioxidant that acts as a natural cell defender against toxins and free radical damage, in response to your unique cellular needs. 
  • Celltrient Cellular Energy features TruNiagen Nicotinamide riboside (NR), which boosts NAD+ to help renew your cells’ natural ability to produce daily energy.  
  • Celltrient Cellular Strength features the cellular nutrient Mitopure Urolithin A (UA) which helps activate the renewal of mitochondria in muscles through a natural process called mitophagy. 

Read Previous

Tetra Pak receives certification for tubular heat exchangers

Read Next

Industry experts explore critical role of micronutrients and nutraceutical products

Leave a Reply